Privia Health Group, Inc. (PRVA)
Automate Your Wheel Strategy on PRVA
With Tiblio's Option Bot, you can configure your own wheel strategy including PRVA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRVA
- Rev/Share 16.6375
- Book/Share 6.213
- PB 3.9006
- Debt/Equity 0.0088
- CurrentRatio 1.6656
- ROIC 0.0232
- MktCap 2771224448.0
- FreeCF/Share 0.9017
- PFCF 25.0332
- PE 152.2532
- Debt/Assets 0.0046
- DivYield 0
- ROE 0.027
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | PRVA | BMO Capital Markets | -- | Outperform | -- | $30 | Nov. 13, 2025 |
| Initiation | PRVA | Needham | -- | Buy | -- | $25 | Jan. 10, 2025 |
| Initiation | PRVA | Macquarie | -- | Outperform | -- | -- | Dec. 16, 2024 |
| Initiation | PRVA | KeyBanc Capital Markets | -- | Overweight | -- | $23 | Oct. 11, 2024 |
News
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q3 Earnings
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Privia Health's Premium: A Breakout Play
Published: October 31, 2025 by: Seeking Alpha
Sentiment: Positive
Privia Health Group offers high-growth potential with a recurring revenue model and strong relationships, making it attractive amid the healthcare sector underperformance. PRVA's recent acquisition of Evolent Health's ACO adds over 120,000 users, boosting revenue streams and raising expectations for the next earnings report. Despite a high forward P/E and a DCF model suggesting downside, technical patterns and sector comps support a potential breakout above $26, targeting $28–$36.
Read More
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors
Published: July 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Berberian brings significant technology leadership and cybersecurity expertise Berberian brings significant technology leadership and cybersecurity expertise
Read More
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Privia Health (PRVA) Misses Q1 Earnings Estimates
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Read More
Privia Health Reports First Quarter 2025 Financial Results
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025.
Read More
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024.
Read More
About Privia Health Group, Inc. (PRVA)
- IPO Date 2021-04-28
- Website https://www.priviahealth.com
- Industry Medical - Healthcare Information Services
- CEO Parth Mehrotra
- Employees 1140